In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Adverse reactions attributed to entire drug class 'Serotonin-norepinephrine reuptake inhibitor'
Please login to view adverse reactions.
- (2017): Y-Hassan S, Int J Cardiol 231, 228
- (2017): Bartlett D, Crit Care Nurse 37(1), 49
- (2015): Zadori D+, Expert Opin Drug Saf 14(6), 877 [REVIEW]
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
- (2023): Zhao Z+, Psychiatr Q Mar, Online ahead of print (26 cases)
- (2012): Letmaier M+, Int J Neuropsychopharmacol 15(6), 739
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
- (2016): Sarosiek I+, Expert Opin Drug Saf 15(7), 937 [REVIEW]
Adverse effects / adverse reactions
- (2014): Carter GT+, Phys Med Rehabil Clin N Am 25(2), 457 [REVIEW]
